BRIEF-Accendra Health, Inc Q2 Adjusted EBITDA USD 60.1 Million Vs. IBES Estimate USD 61.3 Million
Reuters2026/08/10 10:46Aug 10 (Reuters) - Accendra Health, Inc Q2 net income USD -89.07 million.
- Q2 revenue USD 613.2 million vs. IBES estimate USD 627.3 million
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Meme Express: DogWifHat market cap on BSC surpasses $700,000
How to Make Money With Crypto? Apeing’s 1000x Crypto Hype Hits the Final Stretch Before September 8th
Update for XRP Holders: CLARITY Act Faces a Major Timing Problem
AstraZeneca (AZN.US) breast cancer drug receives accelerated FDA approval; Wall Street expects sales to reach 2.3 billions USD by 2032.
AstraZeneca's (AZN.US) oral medication for breast cancer has been approved by the US Food and Drug Administration (FDA).
Crypto prices
More
